Blood Advances (May 2018)
CBL-MZ is not a single biological entity: evidence from genomic analysis and prolonged clinical follow-up
- Helen Parker,
- Neil Robert McIver-Brown,
- Zadie A. Davis,
- Marina Parry,
- Matthew J.J. Rose-Zerilli,
- Aliki Xochelli,
- Jane Gibson,
- Renata Walewska,
- Jonathan C. Strefford,
- David G. Oscier
Affiliations
- Helen Parker
- Cancer Genomics, Academic Unit for Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, United Kingdom;
- Neil Robert McIver-Brown
- Department of Molecular Pathology, Royal Bournemouth Hospital, Bournemouth, United Kingdom;
- Zadie A. Davis
- Department of Molecular Pathology, Royal Bournemouth Hospital, Bournemouth, United Kingdom;
- Marina Parry
- Cancer Genomics, Academic Unit for Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, United Kingdom;
- Matthew J.J. Rose-Zerilli
- Cancer Genomics, Academic Unit for Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, United Kingdom;
- Aliki Xochelli
- Institute of Applied Biosciences, Centre for Research and Technology Hellas, Thessaloniki, Greece;
- Jane Gibson
- Biological Sciences, Faculty of Natural and Environmental Sciences, University of Southampton, Southampton, United Kingdom
- Renata Walewska
- Cancer Genomics, Academic Unit for Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, United Kingdom;; Department of Molecular Pathology, Royal Bournemouth Hospital, Bournemouth, United Kingdom;
- Jonathan C. Strefford
- Cancer Genomics, Academic Unit for Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, United Kingdom;; Jonathan C. Strefford, Cancer Genomics, MP824, Somers Building, Faculty of Medicine, Southampton General Hospital, Tremona Rd, Southampton SO16 6YD, United Kingdom.
- David G. Oscier
- Cancer Genomics, Academic Unit for Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, United Kingdom;; Department of Molecular Pathology, Royal Bournemouth Hospital, Bournemouth, United Kingdom;; David G. Oscier, Department of Molecular Pathology, Royal Bournemouth Hospital, Castle Lane East, Bournemouth BH7 7DW, United Kingdom
- Journal volume & issue
-
Vol. 2,
no. 10
pp. 1116 – 1119